BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16501908)

  • 1. [Recent progress in the treatment of colorectal cancer].
    Thuss-Patience PC; Reichardt P; Riess H; Kretzschmar A
    Med Klin (Munich); 2006 Feb; 101(2):114-9. PubMed ID: 16501908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
    Kelly H; Goldberg RM
    J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy of stage III colon cancer.
    Benson AB
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the treatment of metastatic colorectal cancer.
    Goldberg RM
    Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
    Lee JJ; Chu E
    Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of UFT in metastatic colorectal cancer.
    Bennouna J; Saunders M; Douillard JY
    Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a third-line therapy for metastatic colorectal cancer?
    Grothey A
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S36-8. PubMed ID: 17178284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-line therapy for metastatic colorectal cancer.
    Gundgaard MG; Soerensen JB; Ehrnrooth E
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):1-13. PubMed ID: 17786445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal treatment of metastatic colorectal cancer.
    Pessino A; Sobrero A
    Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
    Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
    J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colon cancer: what is new in 2004?].
    André T; Louvet C; de Gramont A
    Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
    Benson AB
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
    Scheithauer W
    Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for colorectal cancer--an overview of current management for surgeons.
    Lawes D; Taylor I
    Eur J Surg Oncol; 2005 Nov; 31(9):932-41. PubMed ID: 15979268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.